OBJECTIVE: This study is to investigate the inhibitory effect of E1A gene on the cell proliferation of HeLa cells and its mechanism related to apoptosis. METHODS: MTT assay and soft agar colony formation assay were employed to justify the inhibition activity of E1A on the proliferation of HeLa cells transfected with E1A gene. Western Blot, RT-PCR and Real-time quantitative RT-PCR were used to detect the gene expression of E1A, HER-2/Neu and Caspase-3 in HeLa cells, respectively. The Caspase-3 activity was monitored by ApoAlert Caspase-3 Assay. The redistribution of cell cycles and apoptosis of HeLa cells regulated by E1A expression were evaluated by flow cytometry. RESULTS: E1A expression significantly inhibits the cell proliferation and anchorage-independent cell growth of HeLa, with the respective highest inhibition rate of 40.7% and 43.4% (P < 0.01). HER-2/Neu expression in HeLa was significantly down-regulated by E1A, while the protein expression and activity of Caspase-3 was up-regulated by E1A expression. Flow cytometry revealed that E1A transfection in HeLa increased the cell number at G1 stage and simultaneously decreased the cell number at S stage. E1A transfection induced 8.71% of HeLa cells at apoptosis status. CONCLUSIONS: E1A significantly inhibits the cell proliferation of HeLa by the apoptosis induction through HER-2/Neu/Caspase-3 pathway. These results encourage us to continue an in-vivo study and preclinical development of LPD-E1A as a novel gene therapeutic agent for human cervical cancer.
OBJECTIVE: This study is to investigate the inhibitory effect of E1A gene on the cell proliferation of HeLa cells and its mechanism related to apoptosis. METHODS:MTT assay and soft agar colony formation assay were employed to justify the inhibition activity of E1A on the proliferation of HeLa cells transfected with E1A gene. Western Blot, RT-PCR and Real-time quantitative RT-PCR were used to detect the gene expression of E1A, HER-2/Neu and Caspase-3 in HeLa cells, respectively. The Caspase-3 activity was monitored by ApoAlert Caspase-3 Assay. The redistribution of cell cycles and apoptosis of HeLa cells regulated by E1A expression were evaluated by flow cytometry. RESULTS: E1A expression significantly inhibits the cell proliferation and anchorage-independent cell growth of HeLa, with the respective highest inhibition rate of 40.7% and 43.4% (P < 0.01). HER-2/Neu expression in HeLa was significantly down-regulated by E1A, while the protein expression and activity of Caspase-3 was up-regulated by E1A expression. Flow cytometry revealed that E1A transfection in HeLa increased the cell number at G1 stage and simultaneously decreased the cell number at S stage. E1A transfection induced 8.71% of HeLa cells at apoptosis status. CONCLUSIONS: E1A significantly inhibits the cell proliferation of HeLa by the apoptosis induction through HER-2/Neu/Caspase-3 pathway. These results encourage us to continue an in-vivo study and preclinical development of LPD-E1A as a novel gene therapeutic agent for human cervical cancer.
Authors: M B Flinterman; J S Mymryk; P Klanrit; A F Yousef; S W Lowe; C Caldas; J Gäken; F Farzaneh; M Tavassoli Journal: Oncogene Date: 2007-05-07 Impact factor: 9.867
Authors: Yong Jin Chun; In Chul Park; Myung Jin Park; Sang Hyeok Woo; Seok Il Hong; Hee Yong Chung; Tae Hwan Kim; Yun Sil Lee; Chang Hun Rhee; Su Jae Lee Journal: FEBS Lett Date: 2002-05-22 Impact factor: 4.124
Authors: Srinivasan Madhusudan; Ayala Tamir; Nicholas Bates; Elizabeth Flanagan; Martin E Gore; Desmond P J Barton; Peter Harper; Michael Seckl; Hilary Thomas; Nicholas R Lemoine; Mark Charnock; Nagy A Habib; Robert Lechler; Joanna Nicholls; Massimo Pignatelli; Trivadi S Ganesan Journal: Clin Cancer Res Date: 2004-05-01 Impact factor: 12.531
Authors: Alberto Serrano-Olvera; Alfonso Dueñas-González; Dolores Gallardo-Rincón; Myrna Candelaria; Jaime De la Garza-Salazar Journal: Cancer Treat Rev Date: 2006-02-17 Impact factor: 12.111